Sofenacin 5 Mg 30 Capsules

Sofenacin 5 Mg 30 Capsules

Description:

Sofenacin 5 mg 30 capsules is a prescription oral medicine containing solifenacin succinate, a muscarinic receptor antagonist used for the treatment of overactive bladder. It helps control symptoms such as sudden urge to urinate, urinary frequency, and urge urinary incontinence by relaxing the smooth muscles of the bladder. Manufactured by Marcyrl Pharmaceutical Industries (MPI), this product is designed for adult patients under medical supervision to improve bladder control and quality of life.

Indications:

• Treatment of overactive bladder in adults.
• Management of symptoms of urge urinary incontinence (involuntary leakage of urine associated with a strong urge to urinate).
• Reduction of urinary urgency (sudden, compelling desire to pass urine that is difficult to defer).
• Reduction of increased urinary frequency (need to urinate more often than usual).

Active Ingredients / Key Components:

• Solifenacin succinate – 5 mg per film-coated tablet/capsule equivalent to 5 mg solifenacin (exact equivalence not specified in available data).
• Other excipients: Full list of inactive ingredients is not available in the provided information. Please refer to the package leaflet for complete excipient details.

Dosage & Administration / How to Use:

• Usual adult dose: 5 mg once daily, taken at approximately the same time each day, or as directed by your physician.
• In some patients, the dose may be increased by the doctor to 10 mg once daily depending on response and tolerability.
• Swallow the capsule/tablet whole with a glass of water. Do not crush, chew, or break.
• Can be taken with or without food.
• Use regularly as prescribed to achieve optimal control of overactive bladder symptoms; do not stop treatment without consulting your doctor.
• If you miss a dose, take it as soon as you remember unless it is almost time for the next dose. Do not take a double dose to make up for a missed one.
• Not recommended for children and adolescents unless specifically prescribed by a specialist (safety and efficacy in pediatric patients are limited).

Clinical Benefits:

• Helps reduce episodes of urge urinary incontinence, improving continence and daily comfort.
• Decreases urinary urgency and frequency, allowing longer intervals between bathroom visits.
• Improves bladder capacity by relaxing detrusor smooth muscle through muscarinic (m3) receptor antagonism.
• Supports better sleep and quality of life by reducing nocturnal and daytime urinary symptoms.

Warnings & Contraindications:

• Contraindicated in patients with urinary retention, severe gastric retention, uncontrolled narrow-angle glaucoma, or known hypersensitivity to solifenacin succinate or any component of the product.
• Use with caution in patients with clinically significant bladder outlet obstruction, decreased gastrointestinal motility (e.g., severe constipation), gastrointestinal obstructive disorders, or risk of urinary retention.
• Use with caution in patients with hepatic or renal impairment; dose adjustment or close monitoring may be required. Severe hepatic impairment is generally a contraindication.
• May cause blurred vision, dizziness, or drowsiness; avoid driving or operating machinery if affected.
• Use with caution in patients with autonomic neuropathy, hiatal hernia, gastroesophageal reflux disease, or those taking drugs that can cause or worsen QT prolongation (risk of cardiac arrhythmia).
• Consult your doctor before use if pregnant, planning pregnancy, or breastfeeding. Solifenacin should only be used if the potential benefit justifies the potential risk.
• Inform your doctor about all other medications you are taking, especially other anticholinergic drugs, cholinergic agonists, certain antifungals (e.g., ketoconazole), macrolide antibiotics, antiarrhythmics, and drugs metabolized via CYP3A4.
• Not intended to diagnose, treat, cure, or prevent any disease without medical supervision. This is a prescription-only medicine and must be used under the guidance of a healthcare professional.
• Keep out of reach of children.

Side Effects:

• Common side effects: dry mouth, constipation, blurred vision, nausea, indigestion, abdominal discomfort, dry eyes.
• Less common side effects: urinary tract infection, fatigue, dizziness, headache, dry skin, palpitations, edema.
• Serious side effects (seek medical attention immediately): difficulty urinating or inability to pass urine, severe abdominal pain, signs of allergic reaction (rash, itching, swelling of face/lips/tongue, difficulty breathing), severe constipation or bowel obstruction, irregular heartbeat.
• If any side effects persist, worsen, or you notice any unusual symptoms, contact your doctor or pharmacist promptly.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Do not use after the expiry date printed on the pack. Store at or below the temperature specified on the outer packaging (exact temperature range not available in the provided information; typically store below 30°c unless otherwise stated on the pack).

Specifications:

• Strength: 5 mg solifenacin succinate per film-coated tablet/capsule.
• Form: Oral capsule / film-coated tablet (solid oral dosage form).
• Pack size: 30 units per pack.
• Intended use: Prescription medicine for overactive bladder in adults.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.